RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Leaps by Bayer
L

Leaps by Bayer portfolio

Leaps by Bayer has 5 portfolio companies on record at Recent Funding. Its most recent investment on record is Huma Therapeutics's $80M Series B+ round in July 2024, alongside Hitachi Ventures, HAT Sicaf and AstraZeneca. By category, its portfolio leans toward Health and bio (5) and AI agents (1). It has co-invested with General Catalyst, Threshold Ventures and Merck Global Health Innovation Fund, most often General Catalyst (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 5.
Deals, last 12 months: 0.
Capital in their rounds: $264M.
Latest deal: Huma Therapeutics · Jul 16, 2024.

What Leaps by Bayer invests in

Leaps by Bayer recent investments

How Leaps by Bayer invests

StageDealsCapital in rounds
Series B+ 3 100%$264M
YearDealsCapital in rounds
2021 1 33%$58M
2024 2 67%$206M

Share is of the 3 rounds on Recent Funding that name Leaps by Bayer. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Leaps by Bayer portfolio companies

CompanyRound with Leaps by BayerTotal raisedLatest raise
HHuma Therapeutics
AI agents
Series B+ · $80M$118MSep 11, 2024
round
TTranscarent
Health and bio
Series B+ · $126M$384MMay 2, 2024
Series B+
AAndes
Health and bio
backer$30MJan 9, 2026
Seed
CCelea Therapeutics
Health and bio
backer$180MJul 2, 2026
Series A
OOne Bio
Health and bio
backer$27MDec 11, 2024
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Leaps by Bayer, which is a subset of its real portfolio. API: /api/v1/investors/leaps-by-bayer (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy